ALSUntangled #77: Psilocybin
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration December 22, 2024 Bhavya Bakshi, Sandeep Yerraguntla, Carmel Armon et al. 1 citation
ALSUntangled reviews alternate and off-label treatments prompted by patient interest. Here, we review psilocybin, a chemical derived from mushrooms and belonging in the category of drugs known as psychedelics. Psilocybin has plausible mechanisms for slowing ALS progression because of its ability to cross the blood brain barrier and effect neurogenesis and inflammation. Currently, there are no...